Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Qing Zhou

Guangdong Academy of Medical Sciences

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

The CD73-adenosine axis in NSCLC: expression regulation, pro-tumor mechanisms, and combination therapy

Journal of Cancer Research and Clinical Oncology

A narrative review summarizing current evidence on CD73-adenosine biology and therapeutic strategies in NSCLC, without new primary data or meta-analysis.

Expert GuidanceDu Cai Qing Zhou Zi-Rui Ren

Study details

DesignNarrative review

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support